Pacira Biosciences Inc
XBER:82P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacira Biosciences Inc
XBER:82P
|
US |
|
W
|
Williams Companies Inc
XHAM:WMB
|
US |
|
F
|
Fluor Corp
F:FLU
|
US |
|
L
|
Lantheus Holdings Inc
SWB:0L8
|
US |
|
A
|
Abbott Laboratories
XBER:ABL
|
US |
|
B
|
British American Tobacco PLC
NYSE:BTI
|
UK |
|
C
|
Cognizant Technology Solutions Corp
F:COZ
|
US |
|
Airtel Africa PLC
OTC:AARTY
|
UK |
|
Alimentation Couche-Tard Inc
OTC:ANCTF
|
CA |
|
T
|
Telefonica SA
LSE:0A2Y
|
ES |
|
Ritchie Bros Auctioneers Inc
TSX:RBA
|
CA |
|
Arqit Quantum Inc
NASDAQ:ARQQ
|
UK |
|
G
|
Gilead Sciences Inc
SWB:GIS
|
US |
Bankruptcy Probability
Pacira Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Pacira Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Pacira Biosciences Inc
NASDAQ:PCRX
|
986.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
622.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
320.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
221.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
317.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Pacira Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Pacira Biosciences Inc has total debt of 367.7m USD. This includes both short-term (0 USD) and long-term (367.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
